Corix Bioscience (Corix Bioscience) Accounts Payable & Accrued Expense : $0.04 Mil (As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience Accounts Payable & Accrued Expense?

Corix Bioscience's quarterly accounts payable & accrued expense increased from Mar. 2017 ($0.00 Mil) to Jun. 2017 ($0.83 Mil) but then declined from Jun. 2017 ($0.83 Mil) to Sep. 2017 ($0.04 Mil).

Corix Bioscience's annual accounts payable & accrued expense declined from Jan. 2014 ($0.02 Mil) to Jan. 2015 ($0.00 Mil) but then increased from Jan. 2015 ($0.00 Mil) to Dec. 2016 ($0.60 Mil).

Corix Bioscience Accounts Payable & Accrued Expense Historical Data

The historical data trend for Corix Bioscience's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience Accounts Payable & Accrued Expense Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.01

0.02

0.60

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.68	0.60	-	0.83	0.04

Corix Bioscience Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines